| 摘要 |
The present invention relates to processes and methods for undertaking clinical trials using pharmacogenomics-based techniques. In particular, the present invention relates to the collection of circulating RNA in an individual or group of individuals before and after an event or intervention, identifying any changes in circulating RNA before and after such event or intervention and relating such change to the event or intervention but without the need for identification of the protein for which such RNA codes; and using changes in the levels of these RNA transcripts to assess disease progression, remission, therapeutic effect, or development of new treatments.
|
